BUZZ-尼德姆上调 iRhythm Technologies PT

Reuters
14 Jan

((自动化翻译由路透提供,请见免责声明 ))

1月14日 - ** 券商Needham将医疗设备制造商iRhythm Technologies 的目标股价从96美元上调至112美元,维持 "买入 "评级

** 上调后的PT较上一交易日收盘价有14.8%的上涨空间

** 券商预测第四季度营收将超过1.6亿美元,预计为1.575亿美元 - LSEG

** IRTC 的心脏监测设备 Zio monitor 和 Zio AT 推动了公司收入预测的增长 - 经纪公司

** 公司预测 2025 年收入在 6.75 亿美元至 6.85 亿美元之间,经纪公司预计公司将 "进一步提高盈利能力"。

** 2024 年公司股价下跌约 11

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10